PL3606929T3 - Nukleotydy estru beta-nikotynianowego i sposoby ich wytwarzania - Google Patents
Nukleotydy estru beta-nikotynianowego i sposoby ich wytwarzaniaInfo
- Publication number
- PL3606929T3 PL3606929T3 PL18781797T PL18781797T PL3606929T3 PL 3606929 T3 PL3606929 T3 PL 3606929T3 PL 18781797 T PL18781797 T PL 18781797T PL 18781797 T PL18781797 T PL 18781797T PL 3606929 T3 PL3606929 T3 PL 3606929T3
- Authority
- PL
- Poland
- Prior art keywords
- beta
- preparation
- methods
- nicotinate ester
- nucleotides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/02—Phosphorylation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/048—Pyridine radicals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/316—Foods, ingredients or supplements having a functional effect on health having an effect on regeneration or building of ligaments or muscles
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762481912P | 2017-04-05 | 2017-04-05 | |
| PCT/US2018/026209 WO2018187540A1 (en) | 2017-04-05 | 2018-04-05 | Beta-nicotinate ester nucleotides and processes for preparing same |
| EP18781797.8A EP3606929B1 (en) | 2017-04-05 | 2018-04-05 | Beta-nicotinate ester nucleotides and processes for preparing same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3606929T3 true PL3606929T3 (pl) | 2021-12-27 |
Family
ID=63712318
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18781797T PL3606929T3 (pl) | 2017-04-05 | 2018-04-05 | Nukleotydy estru beta-nikotynianowego i sposoby ich wytwarzania |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US10961268B2 (pl) |
| EP (1) | EP3606929B1 (pl) |
| JP (1) | JP7182289B2 (pl) |
| KR (1) | KR102605369B1 (pl) |
| CN (1) | CN110709406B (pl) |
| AU (2) | AU2018250242B2 (pl) |
| CA (1) | CA3059228C (pl) |
| CY (1) | CY1124450T1 (pl) |
| DK (1) | DK3606929T3 (pl) |
| ES (1) | ES2887224T3 (pl) |
| HR (1) | HRP20211296T1 (pl) |
| HU (1) | HUE055521T2 (pl) |
| LT (1) | LT3606929T (pl) |
| PL (1) | PL3606929T3 (pl) |
| PT (1) | PT3606929T (pl) |
| RS (1) | RS62284B1 (pl) |
| SI (1) | SI3606929T1 (pl) |
| SM (1) | SMT202100496T1 (pl) |
| WO (1) | WO2018187540A1 (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1957086T3 (en) | 2005-11-18 | 2018-06-06 | Cornell Res Foundation Inc | NICOTINOYL RIBOSIDE COMPOSITIONS AND METHODS OF USE |
| KR102354784B1 (ko) | 2015-08-05 | 2022-01-25 | 메트로 인터내셔널 바이오테크 엘엘씨 | 니코틴아미드 모노뉴클레오티드 유도체 및 그 용도 |
| GB2542881B (en) | 2015-10-02 | 2020-01-01 | Carr Andrew | Crystal forms of ß-nicotinamide mononucleotide |
| CA3059228C (en) | 2017-04-05 | 2025-03-18 | Cornell University | BETA-NICOTINE ESTER NUCLEOTIDES AND PREPARATION METHODS |
| US20210388018A1 (en) * | 2018-10-01 | 2021-12-16 | Cornell University | Methyl and ethyl nicotinate-riboside-5-phosphates, preparation thereof and methods of use thereof |
| KR102060374B1 (ko) * | 2018-12-14 | 2019-12-30 | 주식회사 휴메딕스 | 지방알코올 컨쥬게이션된 니코틴아미드 리보사이드 유도체 |
| US11939348B2 (en) | 2019-03-22 | 2024-03-26 | Metro International Biotech, Llc | Compositions comprising a phosphorus derivative of nicotinamide riboside and methods for modulation of nicotinamide adenine dinucleotide |
| MX2023013903A (es) | 2021-05-27 | 2023-12-11 | Metro Int Biotech Llc | Solidos cristalinos de mononucleotido de acido nicotinico y esteres de estos y metodos de elaboracion y uso. |
| CN113527376A (zh) * | 2021-08-06 | 2021-10-22 | 上海昶法新材料有限公司 | β-烟酰胺单核苷酸的制备方法 |
| CA3241560A1 (en) | 2021-12-22 | 2023-06-29 | James M. Mckearin | Compositions for treatment of inflammation |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3736314A (en) * | 1967-06-02 | 1973-05-29 | Syntex Corp | Unsaturated nucleoside phosphonates phosphonic acids and phosphonic acid salts |
| DK1957086T3 (en) | 2005-11-18 | 2018-06-06 | Cornell Res Foundation Inc | NICOTINOYL RIBOSIDE COMPOSITIONS AND METHODS OF USE |
| WO2011003018A2 (en) | 2009-07-01 | 2011-01-06 | Cornell University | Halogenated 2-deoxy-lactones, 2'-deoxy--nucleosides, and derivatives thereof |
| US9322049B2 (en) | 2009-12-14 | 2016-04-26 | Cornell University | Activation and activators of SirT6 |
| US9603862B2 (en) | 2009-12-14 | 2017-03-28 | Cornell University | Activation and activators of SIRT5 |
| WO2011146636A2 (en) | 2010-05-18 | 2011-11-24 | Cornell University | Reagents and methods for sirtuin capture |
| ES2785303T3 (es) | 2012-07-16 | 2020-10-06 | Univ Cornell | Nicotinamida ribósido para tratar la pérdida auditiva |
| AU2015270090A1 (en) * | 2014-06-06 | 2016-12-22 | Glaxosmithkline Intellectual Property (No.2) Limited | Nicotinamide riboside analogs and pharmaceutical compositions and uses thereof |
| US20160035539A1 (en) * | 2014-07-30 | 2016-02-04 | Lauri SAINIEMI | Microfabrication |
| WO2016130691A1 (en) | 2015-02-10 | 2016-08-18 | Duke University | Method of treating heart failure |
| US10590160B2 (en) | 2015-03-27 | 2020-03-17 | Cornell University | Efficient synthesis of nicotinamide mononucleotide |
| CN107846883A (zh) * | 2015-06-04 | 2018-03-27 | 可劳迈戴斯有限公司 | 选择性无溶剂磷酸化 |
| WO2017011788A1 (en) | 2015-07-15 | 2017-01-19 | Cornell University | Syntheses, activities, and methods of use of dihydronicotinamide riboside derivatives |
| CA3059228C (en) | 2017-04-05 | 2025-03-18 | Cornell University | BETA-NICOTINE ESTER NUCLEOTIDES AND PREPARATION METHODS |
| US20210388018A1 (en) | 2018-10-01 | 2021-12-16 | Cornell University | Methyl and ethyl nicotinate-riboside-5-phosphates, preparation thereof and methods of use thereof |
-
2018
- 2018-04-05 CA CA3059228A patent/CA3059228C/en active Active
- 2018-04-05 WO PCT/US2018/026209 patent/WO2018187540A1/en not_active Ceased
- 2018-04-05 SI SI201830363T patent/SI3606929T1/sl unknown
- 2018-04-05 HR HRP20211296TT patent/HRP20211296T1/hr unknown
- 2018-04-05 EP EP18781797.8A patent/EP3606929B1/en active Active
- 2018-04-05 CN CN201880036949.3A patent/CN110709406B/zh active Active
- 2018-04-05 US US16/603,164 patent/US10961268B2/en active Active
- 2018-04-05 PT PT187817978T patent/PT3606929T/pt unknown
- 2018-04-05 RS RS20211045A patent/RS62284B1/sr unknown
- 2018-04-05 ES ES18781797T patent/ES2887224T3/es active Active
- 2018-04-05 AU AU2018250242A patent/AU2018250242B2/en active Active
- 2018-04-05 PL PL18781797T patent/PL3606929T3/pl unknown
- 2018-04-05 DK DK18781797.8T patent/DK3606929T3/da active
- 2018-04-05 SM SM20210496T patent/SMT202100496T1/it unknown
- 2018-04-05 LT LTEPPCT/US2018/026209T patent/LT3606929T/lt unknown
- 2018-04-05 KR KR1020197032663A patent/KR102605369B1/ko active Active
- 2018-04-05 HU HUE18781797A patent/HUE055521T2/hu unknown
- 2018-04-05 JP JP2019555021A patent/JP7182289B2/ja active Active
-
2021
- 2021-03-29 US US17/216,533 patent/US11530233B2/en active Active
- 2021-08-19 CY CY20211100746T patent/CY1124450T1/el unknown
- 2021-10-15 AU AU2021250984A patent/AU2021250984B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PT3606929T (pt) | 2021-09-02 |
| EP3606929B1 (en) | 2021-06-02 |
| WO2018187540A1 (en) | 2018-10-11 |
| LT3606929T (lt) | 2021-10-25 |
| AU2018250242B2 (en) | 2021-07-15 |
| DK3606929T3 (da) | 2021-08-23 |
| US20210214386A1 (en) | 2021-07-15 |
| SI3606929T1 (sl) | 2021-11-30 |
| ES2887224T3 (es) | 2021-12-22 |
| CY1124450T1 (el) | 2022-07-22 |
| JP7182289B2 (ja) | 2022-12-02 |
| HUE055521T2 (hu) | 2021-11-29 |
| EP3606929A1 (en) | 2020-02-12 |
| US10961268B2 (en) | 2021-03-30 |
| RS62284B1 (sr) | 2021-09-30 |
| CN110709406B (zh) | 2022-11-08 |
| HRP20211296T1 (hr) | 2021-11-12 |
| KR102605369B1 (ko) | 2023-11-24 |
| AU2021250984A1 (en) | 2021-11-18 |
| SMT202100496T1 (it) | 2021-11-12 |
| CA3059228A1 (en) | 2018-10-11 |
| CA3059228C (en) | 2025-03-18 |
| CN110709406A (zh) | 2020-01-17 |
| AU2018250242A1 (en) | 2019-10-31 |
| US20200031860A1 (en) | 2020-01-30 |
| KR20190137133A (ko) | 2019-12-10 |
| US11530233B2 (en) | 2022-12-20 |
| EP3606929A4 (en) | 2020-05-06 |
| AU2021250984B2 (en) | 2022-09-01 |
| JP2020516619A (ja) | 2020-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3606929T3 (pl) | Nukleotydy estru beta-nikotynianowego i sposoby ich wytwarzania | |
| IL271025A (en) | Multibiotic agents and methods of using the same | |
| IL293377B1 (en) | Hsd17b13 variants and uses thereof | |
| PL3601358T3 (pl) | Przeciwciała anty-trem2 i sposoby ich wykorzystania | |
| IL282048A (en) | Oxysterols and methods of use thereof | |
| PL3250610T3 (pl) | Przeciwciała anty-FcRn i sposoby ich stosowania | |
| IL259747A (en) | Antibodies targeting fc receptor-like 5 and methods of use | |
| IL255269A (en) | Compositions of obeticholic acid and methods of use | |
| PL3828194T3 (pl) | Oksysterole i sposoby ich stosowania | |
| IL269334A (en) | Improved t cell compositions and methods | |
| IL254039A0 (en) | Anti-pvrig antibodies and methods of use | |
| IL257203B (en) | 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as magl inhibitors | |
| PL3183260T3 (pl) | Modyfikowane oligonukleotydy i sposoby ich syntezy | |
| PL3353210T3 (pl) | Przeciwciała anty-TIGIT i sposoby stosowania | |
| PL3215532T3 (pl) | Przeciwciała anty-TIM3 i sposoby ich zastosowania | |
| PL3445850T3 (pl) | Sposoby otrzymywania jednoniciowego rna | |
| PL3394259T3 (pl) | Kompozycje i sposoby zmniejszania ekspresji tau | |
| PL3277270T3 (pl) | Kompozycje i sposoby leczenia niedokrwistości | |
| PT3325669T (pt) | Composições e métodos de análise de rna | |
| HUE046756T2 (hu) | Benzoxazepin-oxazolidinon vegyületek és azok alkalmazási módszerei | |
| IL256322B (en) | Improved formulations of deferasirox and methods of making the same | |
| IL254670A0 (en) | Humanized anti-c1s antibodies and methods of use thereof | |
| JP2018172409A5 (ja) | １５−ｈｅｐｅを含む組成物および同組成物を使用する方法 | |
| PL3389636T3 (pl) | Kompozycje i metody wytwarzania mikrocząstek białkowych | |
| DK3182962T3 (da) | Compositions and uses of amidine derivatives |